Years of Misdiagnosis Yield Hope in Autoimmune Disease Research

A Massachusetts woman’s decade-long battle for diagnosis, ultimately revealing lupus, is highlighting both the challenges of autoimmune disease detection and the promising advancements being made in treatment and potential cures.

Ruth Wilson, 43, of Littleton, Massachusetts, experienced years of dismissed symptoms – rashes, swelling, fevers, and severe pain – before a final emergency room visit and a persistent request for further testing revealed her kidneys were failing due to lupus, an autoimmune disease where the body attacks its own tissues. “I just wish there was a better way that patients could get that diagnosis without having to go through all of the pain and all of, like, the dismissiveness and the gaslighting,” Wilson said. Autoimmune diseases, affecting as many as 50 million Americans, are increasingly recognized as a significant public health concern.

Scientists are now building on breakthroughs in cancer research and the COVID-19 pandemic to decode the underlying biology of these complex illnesses. Researchers at the National Institutes of Health are identifying pathways leading to different autoimmune diseases and connections between them, with the goal of targeting the root causes rather than just managing symptoms. Early results with CAR-T therapy, a treatment utilizing a patient’s own immune cells, show promise, with one lupus patient in Germany remaining in drug-free remission since March 2021. Another drug, teplizumab, has demonstrated the ability to delay the onset of Type 1 diabetes symptoms. This research builds on the understanding that autoimmune diseases are not single entities, but rather a spectrum of conditions with shared characteristics, as explored in studies of lupus.

Researchers are also focusing on neutrophils, a type of white blood cell, and their potential role in triggering autoimmune responses. Dr. Mariana Kaplan of NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases explained that non-genetic factors, such as infections and environmental pollutants, can also play a significant role in triggering the immune system’s attack. Wilson is now participating in the Lupus Landmark Study, contributing biological samples to further research and advocating for patient voices to be included in the development of new therapies. Officials stated that continued funding and research are crucial to accelerating progress in this field.